Patient B (NF2-mutated tumours) on the other hand, had TERT promoter and NF1 mutations in all tumour grades, suggesting that a TERT promoter mutation is not an oncogenic driver, from Grade 2 to 3, as it was also present in the Grade 2 tumour. This evidence concerns the gene NF1 and neoplasm.